 optim dose neurolept acut schizophrenia control studi neurolept threshold haloperidol dose individu determin neurolept threshold NT haloperidol patient schizophrenia schizoaffect disord research diagnost criteria dose mean mg/d week patient unavail follow-up subsequ random non-respond patient random patient double-blind dosag haloperidol time mean mg/d NT dosag mean mg/d week patient NT dosag haloperidol trial dosag patient improv measur psychosi declin measur hostil dosag lead signific increas extrapyramid side effect